RE:RE:RE:ADC targeting SORT1 They did not chose PDC over ADC.They purchased Katana 5-6 years ago which had been trying to find a Buyer for more than a year and was not able to get a deal with any pharnas/biotechs involved in oncology...So THTX was apparently the only suitor .... no expertise in oncology .no corporate stucture to support going into R&D and no financial means to see this novel platform thru ....Of course at the time of the purchase it was getting hot in the kitchen with Trogarzo sales failing miserably ....Hoping for positive results of course but with low expectations unless a real oncology compagny decides to partner with THTX .....
Mannequin wrote: But a PDC should be able to work its way in and release payload better than ADC. There's reasons they chose PDC.